D. E. Shaw & Co., Inc. - BELLICUM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$151,000
+1272.7%
116,811
+974.4%
0.00%
Q3 2019$11,000
-96.7%
10,872
-62.9%
0.00%
-100.0%
Q3 2017$338,000
+0.9%
29,287
+2.1%
0.00%0.0%
Q2 2017$335,00028,6950.00%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
EMORY UNIVERSITY 95,215$1,297,0001.28%
Baker Brothers Advisors 4,865,647$66,270,0000.65%
Eventide Asset Management 250,000$3,405,0000.22%
MCDANIEL TERRY & CO 76,112$1,037,0000.22%
SUFFOLK CAPITAL MANAGEMENT LLC 82,538$1,124,0000.15%
QVT Financial LP 337,923$4,603,0000.14%
KENNEDY CAPITAL MANAGEMENT LLC 478,465$6,517,0000.11%
Vident Investment Advisory, LLC 47,157$642,0000.08%
Tekla Capital Management LLC 60,000$817,0000.04%
First Eagle Investment Management, LLC 775,254$10,559,0000.03%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders